HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $27 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.9%

Neg 0% Neu 88.9% Pos 0%

HC Wainwright & Co. analyst Robert Burns reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $27 price target.

Comments

No comments yet. Be the first!